Stomach cancer, though not as common as some other forms of cancer, can be a serious and life-threatening condition if not ...

Two Phase 3 trials presented at Europe's leading oncology conference show major survival gains: Roche's divarasib outperforms ...

AstraZeneca's experimental antibody-drug conjugate sonesitatug vedotin has doubled overall survival in a late-stage trial for ...

AstraZeneca's groundbreaking cancer drug significantly boosts stomach cancer survival rates, offering hope to patients.

NG-350A received FDA fast track designation for mismatch repair-proficient locally advanced rectal cancer, addressing a significant unmet need in treatment options. Imfinzi combined with FLOT ...

Gastrointestinal diseases are those that affect any section of the gastrointestinal tract, from the oesophagus to the rectum, and the accessory digestive organs – liver, gall bladder and pancreas. The ...

Please provide your email address to receive an email when new articles are posted on . There are many misconceptions about gastroparesis and gaps in guidance can make it difficult for patients to be ...

Scientists have discovered that a potential new drug can reverse severe fatty liver disease in animal models by restoring gut ...

Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Gastrointestinal Drugs Market - A Global and Regional Analysis: Focus on Application, Route of Administration, Distribution Channel, Drug Class, and ...

First Tracks Biotherapeutics reported what it called positive top-line results from an early-stage trial of its treatment for celiac disease. The company said Monday its treatment, ANB033, achieved a ...